FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MJ Berg

Research Profile

Chemicals & Drugs

Physiology

Disorders

Objects

Fortified Food

Occupations

Pharmacogenetics

Concepts & Ideas

Procedures

Adsorption

Phenomena

Food-Drug Interactions

Co-author Network

Publications

TOP 3
MJ Berg; Don C Van Dyke; Catherine Chenard; Jennifer R Niebyl; S Hirankarn; A Bendich; Phyllis J Stumbo
Folate, zinc, and vitamin B-12 intake during pregnancy and postpartum.
Don C Van Dyke; Vicki E Ringold; MJ Berg; Jennifer R Niebyl; A L Sherbondy; Dimitri Trembath
Pharmacogenetic screening for susceptibility to fetal malformations in women.
MJ Berg
Pharmacokinetics and pharmacodynamics of cardiovascular agents.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MJ Berg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: MJ Berg; Don C Van Dyke; Catherine Chenard; Jennifer R Niebyl; S Hirankarn; A Bendich; Phyllis J Stumbo
Folate, zinc, and vitamin B-12 intake during pregnancy and postpartum.
Journal of the American Dietetic Association 2001;101(2):242-5.
2000: Don C Van Dyke; Vicki E Ringold; MJ Berg; Jennifer R Niebyl; A L Sherbondy; Dimitri Trembath
Pharmacogenetic screening for susceptibility to fetal malformations in women.
The Annals of pharmacotherapy 2000;34(5):639-45.
1999: MJ Berg
Pharmacokinetics and pharmacodynamics of cardiovascular agents.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1999;2(4):22-4.
1999: MJ Berg
The importance of folic acid.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1999;2(3):24-8.
1999: MJ Berg
Drugs and smoking.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1999;2(2):27-30.
1999: MJ Berg
Drugs, vitamins, and gender.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1999;2(1):18-20.
1998: MJ Berg
Gender-specific prescribing: medications and the menstrual cycle.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1998;1(3):17-9.
1998: MJ Berg
Antipsychotic medications and ethnicity.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1998;1(2):16-7.
1998: DP Lewis; Don C Van Dyke; Phyllis J Stumbo; MJ Berg
Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid: pharmacology, therapeutic recommendations, and economics.
The Annals of pharmacotherapy 1998;32(10):1087-95.
1998: MJ Berg
Drugs, vitamins, and gender.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 1998;1(1):10-1.
1998: DP Lewis; Don C Van Dyke; Phyllis J Stumbo; MJ Berg
Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid.
The Annals of pharmacotherapy 1998;32(9):947-61.
1998: DP Lewis; Don C Van Dyke; Phyllis J Stumbo; MJ Berg
Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
The Annals of pharmacotherapy 1998;32(7-8):802-17.
1997: MJ Berg
Status of research on gender differences.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 1997;NS37(1):43-56.
1995: D P Lewis; Don C Van Dyke; L A Willhite; Phyllis J Stumbo; MJ Berg
Phenytoin-folic acid interaction.
The Annals of pharmacotherapy 1995;29(7-8):726-35.
1995: MJ Berg; Phyllis J Stumbo; C A Chenard; R W Fincham; P J Schneider; D D Schottelius
Folic acid improves phenytoin pharmacokinetics.
Journal of the American Dietetic Association 1995;95(3):352-6.
1994: N B Modi; Peter Veng-Pedersen; Dale Eric Wurster; MJ Berg; D D Schottelius
Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.
Pharmaceutical research 1994;11(2):318-23.
1992: MJ Berg; R W Fincham; B E Ebert; D D Schottelius
Phenytoin pharmacokinetics: before and after folic acid administration.
Epilepsia 1992;33(4):712-20.
1992: D S Collier; MJ Berg; R W Fincham
Parkinsonism treatment: Part III--Update.
The Annals of pharmacotherapy 1992;26(2):227-33.
1992: G M Burke; Dale Eric Wurster; MJ Berg; Peter Veng-Pedersen; D D Schottelius
Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS): correlation with phenobarbital adsorption data.
Pharmaceutical research 1992;9(1):126-30.
1991: Don C Van Dyke; MJ Berg; C H Olson
Differences in phenytoin biotransformation and susceptibility to congenital malformations: a review.
DICP : the annals of pharmacotherapy 1991;25(9):987-92.
1991: G M Burke; Dale Eric Wurster; V Buraphacheep; MJ Berg; Peter Veng-Pedersen; D D Schottelius
Model selection for the adsorption of phenobarbital by activated charcoal.
Pharmaceutical research 1991;8(2):228-31.
1988: Dale Eric Wurster; G M Burke; MJ Berg; Peter Veng-Pedersen; D D Schottelius
Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals.
Pharmaceutical research 1988;5(3):183-6.
1988: MJ Berg; R W Fincham; B E Ebert; D D Schottelius
Decrease of serum folates in healthy male volunteers taking phenytoin.
Epilepsia 1988;29(1):67-73.
1987: MJ Berg; B E Ebert; R W Fincham; D D Schottelius
Phenytoin binding in healthy volunteers.
Therapeutic drug monitoring 1987;9(4):384-8.
1987: MJ Berg; B E Ebert; M P Rivey; D D Schottelius
Utilization of Km for phenytoin dosage after folate addition to patient regimen.
Therapeutic drug monitoring 1987;9(3):304-5.
1987: MJ Berg; B Ebert; D K Willis; T Host; R W Fincham; D D Schottelius
Parkinsonism--drug treatment: Part II.
Drug intelligence & clinical pharmacy 1987;21(2):167-72.
1987: MJ Berg; J Q Rose; Dale Eric Wurster; S Rahman; R W Fincham; D D Schottelius
Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital.
Therapeutic drug monitoring 1987;9(1):41-7.
1987: MJ Berg; B Ebert; D K Willis; T Host; R W Fincham; D D Schottelius
Parkinsonism--drug treatment: Part I.
Drug intelligence & clinical pharmacy 1987;21(1 Pt 1):10-21.
1986: W R Gillespie; Peter Veng-Pedersen; MJ Berg; D D Schottelius
Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal.
Journal of pharmacokinetics and biopharmaceutics 1986;14(1):19-28.
1984: M P Rivey; D D Schottelius; MJ Berg
Phenytoin-folic acid: a review.
Drug intelligence & clinical pharmacy 1984;18(4):292-301.
1983: MJ Berg; M P Rivey; BA Vern; L J Fischer; D D Schottelius
Phenytoin and folic acid: individualized drug-drug interaction.
Therapeutic drug monitoring 1983;5(4):395-9.
1983: MJ Berg; L J Fischer; M P Rivey; BA Vern; R K Lantz; D D Schottelius
Phenytoin and folic acid interaction: a preliminary report.
Therapeutic drug monitoring 1983;5(4):389-94.
1983: MJ Berg; R K Lantz; R D Schoenwald; M I Clarke; D D Schottelius
Optimization of pharmacokinetic monitoring: I. Linear pharmacokinetics.
Therapeutic drug monitoring 1983;5(4):379-87.